Student and Alumni Profiles

"This profession will enable me to be on the front line in the effort to identify the root causes of diseases and come up with solutions to help relieve society's illnesses," Rakibou said.

Read about Rakibou

Captioned Video


Paul Johnson, PhD, MBA, MT

Paul Johnson, PhD, MBA, MT
Appointed 08/16/12
2156 Weiskotten Hall
766 Irving Ave.
Syracuse, NY 13210

315 464-5337

Current Appointments

Hospital Campus

Education & Fellowships

  • PhD: University of Louisville School of Medicine, 2011, Biochemistry, Molecular Biology
  • MBA: University of Illinois at Chicago, 2004

Clinical Interests

  • Vitamin D

Research Interests

  • Metabolomics, Biomarkers

Specialties & Certification

  • Medical Technology (MT) (ASCP)


  • American Society for Clinical Pathology
  • American Association for Clinical Chemistry, Upstate New York Section Program Chair


Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)


Dr. Johnson began his professional career as a clinical laboratory scientist in 1998 after obtaining medical technology board certification by the American Society for Clinical Pathology. He later earned his doctorate in Biochemistry and Molecular Biology from the University of Louisville School of Medicine. Since joining the Upstate faculty in 2012, he has been teaching clinical biochemistry and statistics courses related to pathology and laboratory medicine.

As a research investigator on two current projects, Dr. Johnson is studying the human metabolome in otherwise healthy, Vitamin D deficient subjects using Liquid Chromatography Mass Spectrometry (LC-MS) technology. He is also analyzing clinical serum biomarkers of concussion in human subjects and correlating this data with physical testing of subjects, performed in conjunction with a faculty colleague in the physical therapy education department.

Recent Publications

  • Wu R, Kausar H, Johnson P, Montoya-Durango DE, Merchant M, Rane MJ. Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex. J. Biol. Chem. 2007; 282(30):21598-608.
  • Johnson PR. Down-regulation of bile acid synthesis and a metabolic co-activator under hypoxic conditions - implications in obstructive sleep apnea. Med Hypotheses. 2008;71(4):530-536.
  • El Haibi CP, Sharma PK, Singh R, Johnson PR, Suttles J, Singh S, Lillard JW Jr. PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells. Mol Cancer. 2010 Apr 22;9(1):85.
  • Johnson PR, Shah PP, Barati MT, Gozal E, Rane MJ. Molecular chaperones: ubiquitous proteins with great diversity of function in health and disease. Current Topics in Biochemical Research. 2015; 16: 53-65.

Recent Abstracts

  • Johnson PR, Neville CG.  Evaluation of serum biomarker assays for mild traumatic brain injury in a cohort of mixed martial arts fighters. American Association for Clinical Chemistry (AACC) Annual Meeting, August 2016, Philadelphia, PA.
Faculty Profile Shortcut: